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A Phenotype of Primary Open-angle Glaucoma With
Systemic Vasospasm
Reza Alizadeh, MD,* Laura Vickers, MD,* Pradtana Hirunpatravong, MD,*
Pablo Romero, MD,* Mark C. Lin, MD,* Farideh Shariﬁpour, MD,†
and Joseph Caprioli, MD*
Purpose: Primary open-angle glaucoma (POAG) patients constitute
a heterogenous group. Identiﬁcation of phenotypic subtypes among
these patients may provide a deeper understanding of the disease
and aid associations with genotypes. We describe a phenotype of
POAG patients associated with a constellation of systemic dis-
orders; patients with this phenotype seem to be vulnerable to optic
nerve damage at low intraocular pressures.
Materials and Methods: In this retrospective study, we evaluated the
medical records of active Jules Stein Eye Institute glaucoma patients
from January 1996 to 2017 and included subjects with POAG,
acquired pits of the optic nerve (APON), and at least one of the
following: systolic blood pressure persistently ≤ 100mmHg, history
of migraine headaches or migraine variant, and the Raynaud
syndrome.
Results: Of 87 patients (125 eyes) with APON, 37 patients (55 eyes)
met the study criteria. In total, 34 patients were female (92%). The
median age at the time of diagnosis was 55 years. Nineteen patients
(73%) had low systolic blood pressures, same number had Raynaud
syndrome, and 25 (68%) had a history of migraine.
Conclusions: We describe a POAG subtype with APON and sys-
temic vascular instability, predominantly female in their sixth dec-
ade of life who demonstrate progressive glaucomatous visual ﬁeld
damage at low intraocular pressure. We suggest that this clinical
picture represents an important phenotype of POAG, and that
identiﬁcation and further study of it will help guide diagnosis and
development of individualized treatments.
Key Words: vasospasm, primary open-angle glaucoma, migraine
headache, Raynaud disease, low systemic blood pressure, acquired
pits of the optic nerve
(J Glaucoma 2018;27:987–992)
V arious patterns of glaucomatous optic nerve damagehave been identiﬁed which may correspond to different
patterns of visual ﬁeld loss.1,2 As the development and
application of genome-wide association studies (GWAS), we
are learning more about the heterogeneity of glaucoma as a
disease.3 Many genes and single nucleotide polymorphisms
have been discovered in association with primary open-
angle glaucoma (POAG). However, beneﬁcial clinical
applications of these discoveries is hampered by our poor
ability to sufﬁciently phenotype different subsets of patients
with POAG. Establishing the association of various single
nucleotide polymorphisms and genes with their respective
phenotypic variants of POAG, if any, may allow us to target
our monitoring and treatment algorithms for certain groups
of patients; this will require the deﬁnition of identiﬁable
clinical phenotypes.3,4 In addition, identifying phenotypic
subclasses of glaucomatous optic nerve damage can be
helpful in aiding clinicians in diagnosis and treatment.5
One distinct pattern of optic nerve damage with cor-
responding visual ﬁeld loss is the acquired pits of the optic
nerve (APON). APON was ﬁrst described in 1977 as a focal
loss of neural tissue associated with pronounced excavation
and loss of normal architecture of the lamina cribrosa.6,7
Radius et al8 reported the ﬁrst cases of APON in glaucoma
patients, whereas Spaeth9 and Javitt et al10 conﬁrmed and
further described the presence of this type of optic nerve
damage in glaucoma. APON is more frequently observed in
patients with what has been described as normal tension
glaucoma (NTG).11,12 The associated visual ﬁeld loss tends
to be deep, with sharply delineated scotomata near and
sometimes involving ﬁxation.6,7,11–13 APON has also been
shown to be a risk factor for rapid visual ﬁeld loss.12
This case series describes a subgroup of POAG patients
who have APON and risk factors for systemic vascular
instability including migraine headache, Raynaud phe-
nomenon, and low blood pressure (BP). We propose that
this group represents a phenotypic subtype of POAG in
which signs and symptoms of vasospasm are associated
ﬁndings, and which may contribute to their optic nerve
vulnerability.
MATERIALS AND METHODS
The study protocol was approved by the Institutional
Review Board at the University of California Los Angeles
(UCLA), and all study procedures adhered to the recom-
mendations of the Declaration of Helsinki and conformed to
HIPAA policy. All charts of POAG patients examined in the
Glaucoma Division of the Stein Eye Institute, UCLA, Los
Angeles, California, from January 1996 to 2016 and who have
had a visit within 12 months of the start of data collection (total
of 2547 charts) were reviewed. Those with acceptable quality
optic nerve stereoscopic photographs, which includes nearly
1000 imaging, were screened for the presence of APON by an
experienced glaucoma specialist (J.C.) by examination of the
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photographs. The criteria for the presence of APON were
similar to previously published descriptions.10–12
(1) A sharply localized depression or absence of visible
lamina cribrosa, with deep excavation and loss of
normal laminar architecture, located at the inferotem-
poral or superotemporal pole of the optic disc, and
distinct from the appearance of the classic congenital pit
of the optic nerve.
(2) Extension of the APON to the outer edge of the disc so
that little or no rim tissue remained adjacent to the pit.
(3) No evidence of coloboma or subretinal ﬂuid.
In addition to the above criteria, a reference stereo-
scopic optic disc photograph was used to deﬁne APON
(Fig. 1). Three experienced, masked, independent observers
then examined the stereoscopic photographs and conﬁrmed
or denied the presence and location of APON. The decision
about the presence or absence of an APON was made by
agreement of at least 2 observers (not including J.C.).
Optical coherent tomography was not used to conﬁrm the
presence of APON. Patients with any ocular or intracranial
disease affecting the optic disc or visual ﬁeld were excluded
(including but not limited to intracranial mass, central ret-
inal vein/artery occlusion, branch retinal vein/artery occlu-
sion, and pathologic myopia).
Patients included in this study had POAG and APON with
any one of the following: systolic BP persistently <100mmHg
without medication, a history of migraine or migraine variant
headache, and symptoms of Raynaud syndrome or phenom-
enon. Patients were screened for these underlying medical con-
ditions by self-reported history. To avoid recall bias, only patients
with conﬁrmed diagnosis by physician were included and patients
with only self-reported problems were excluded. Medical records
were reviewed and the following information was recorded:
ethnicity, systemic conditions and medications, APON location
and laterality, age at the time of diagnosis, family history of
glaucoma, sex, history of intraocular surgery, spherical equivalent
and refractive error, central corneal thickness, and presence of
peripapillary atrophy. Best-corrected visual acuity, number of
glaucoma medications, and intraocular pressure (IOP) were
recorded at each visit. All patients with documented untreated
IOP never higher than 21mmHg were considered as NTG.
All visual ﬁelds were obtained with the Humphrey
Field Analyzer 630 (Program 30-2 or 24-2, SITA Standard
algorithm; Humphrey Instruments Inc., San Leandro, CA).
An acceptably reliable visual ﬁeld defect was deﬁned as one
with <30% false-positive responses, false-negative responses,
and ﬁxation losses. Typical glaucomatous visual ﬁeld defects
were deﬁned in 2 consecutive, reliably performed, baseline
automated threshold ﬁeld tests as having an abnormal
Glaucoma Hemiﬁeld test or pattern SD and at least 1 of the
following 3 criteria: ≥ 2 adjacent points with P< 0.01 or
greater loss in the superior arcuate or inferior arcuate zones,
compared with perimeter-deﬁned age-matched normal val-
ues; ≥ 3 adjacent points with P< 0.05 or greater loss in the
superior arcuate or inferior arcuate zones; or a 10 dB dif-
ference across the nasal horizontal midline in ≥ 2 adjacent
locations (Fig. 1).
RESULTS
Of 87 patients (125 eyes) with APON, 37 patients (55
eyes) met the study criteria. The expert panel did not agree
on 25 eyes with APON and they were excluded from study.
In total, 37 patients (55 eyes) met the inclusion criteria
for this series (Table 1) with a median follow-up of 10.8 years
(range, 0.9 to 31.7 y). In total, 34 patients (92%) were female,
and median age at diagnosis of POAG was 55.1 years
(range, 19.9 to 79.3 y) (Fig. 2). Median treated IOP during
the follow-up period was 13mmHg (range, 7 to 40mmHg)
(Fig. 3). The mean ( ±SD) number of glaucoma medications
used was 1.3± 1.2. A visual ﬁeld defect within 10 degrees of
ﬁxation was observed in 44 eyes (80%). In 48 eyes (87%), the
APON was located inferiorly, and bilateral APON was
noted in 18 patients (49%). Low BP and Raynaud disease
had the same incident and were found in 19 patients (73%),
whereas history of migraine headache or migraine variant
had a lower incident and was present in 25 patients (68%).
Baseline mean deviation (MD) and visual ﬁeld index (VFI)
was −5.55± 6.10 dB and 84.2%±18.2%, respectively. In
total, 42 patients had at least 1 year of follow-up and at least
6 reliable visual ﬁelds to calculate the rate of MD and VFI
change. In this group of patients, rate of MD change was
−0.33± 0.7 dB/year (P< 0.001) and VFI was −1.0%±2.0%/
year (P< 0.001). Examples of the optic nerve appearance
with the corresponding visual ﬁelds can be seen in Figure 4.
Among the 37 patients in this series, a subgroup of 21
patients (57%) had ≥ 2 systemic risk factors for vasospasm.
FIGURE 1. The standard stereoscopic optic disc photograph used to define APON with the pattern deviation plot from 30-2 visual field
perimetry. An inferior APON is visible in this optic nerve with corresponding pronounced defect within 5 degrees of fixation. APON
indicates acquired pits of the optic nerve.
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Within this cohort, all patients were female and the median
IOP during the follow-up time was 12 mmHg (range, 1 to
30 mmHg). Median age in this subgroup was 53.8 years
(range, 26.6 to 69.1 y), and median duration of follow-up
was 10.8 years (range, 0.9 to 21.4 y). In 28 eyes (93%) of this
subgroup, a scotoma within 10 degrees of ﬁxation was
present. Bilateral APON was observed in 21 patients (30%).
Seventeen patients in this subgroup had been diagnosed with
low BP (81% of this subgroup); the remaining 4 patients
were the only patients in the entire series with a history of
smoking. Migraine headache and Raynaud syndrome were
present in 16 patients (76%).
DISCUSSION
To help develop clinical innovations based on genome-wide
association studies, genetic ﬁndings should be associated with
phenotypic subclasses of glaucoma patients. A comprehensive
subgroup analysis of clinical glaucoma subtypes is therefore an
important step,3,4 and is not feasible unless distinct phenotypes of
glaucoma, even though differences may be subtle, are ﬁrst more
elaborately deﬁned. We believe the description of a phenotype
we term as “POAG, vasospastic subtype” can forward this goal,
and also help clinicians in guiding the best, individualized
treatment options.
The APON is a distinct structural variant of optic nerve
damage, deﬁned as a deep, localized excavation of neural rim
with localized depression and loss of normal laminar archi-
tecture of the lamina cribrosa. The affected area is pale and
has little or no rim tissue remaining adjacent to the disc
edge.9,10 APON has been identiﬁed as a risk factor for rapid
progression of visual ﬁeld loss,11–15 and perimetric and opti-
cal coherent tomography studies14,16 have shown that this
loss is focal and corresponds to the location of the APON.15
It is postulated that some APONs may represent laminar
disinsertions from the peripapillary scleral infrastructure and
that clinically obscured laminar disinsertions may be a pre-
cursor to APON.17 Laminar disinsertions occurs twice as
frequently in eyes with optic disc hemorrhage18 and is a risk
factor for glaucomatous visual ﬁeld progression.19
In this series, we describe 37 patients with APON,
mostly female and middle-aged with at least 1 systemic
manifestation of vasospasm (low systemic BP, migraine, or
Raynaud phenomenon). Although low systemic BP is not
always a manifestation of vasospasm, none of these patients
had a history of iatrogenically low BP from overtreatment,
or from known autonomic vascular dysregulation. In the
subgroup with at least ≥ 2 systemic vasospastic risk factors,
all patients were female and had low IOPs. Previous studies
have well described this vasospastic type of NTG and have
showed similarly that systemic vasospastic conditions such
as migraine headache and Raynaud phenomena are more
prevalent in NTG patients.10,12,20–22
TABLE 1. Demographic Characteristic for Patients With Primary
Open-angle Glaucoma, Vasospastic Type
At Least 1 Systemic
Vasospastic Condition
≥ 2
Vasospastic
Conditions
No. patients 37 21
No. eyes 55 30
Age (y) 53.2± 14.4 54.1± 10.9
Sex
Female 34 (92) 8 (100)
Male 3 (8) 0 (0)
Race
Caucasian 17 (46) 10 (48)
Other 20 (54) 11 (52)
Right/left eye 27/28 15/15
Low systolic blood
pressure
16 (72.7) 17 (81)
Raynaud disease 19 (51) 16 (76)
History of migraine or
migraine variant
headache
25 (68) 16 (76)
All IOP< 21mmHg 30 (54.5) 30 (100)
Mean IOP 13.5± 4.7 12.6± 3.6
No. medication 1.3± 1.2 1.3± 1.1
Inferior APON 48 (87) 24 (80)
Bilaterality 18 (48.6) 9 (30)
Central corneal thickness
(μm)
553± 40 545± 39.2
Visual acuity (logMAR) 0.1± 0.6 0.06± 0.04
Glaucoma surgery 20 (36) 8 (26)
Topical beta blocker
usage
35 (64) 16 (53)
Spherical equivalent −3.9 ± 0.6 −4.1 ± 0.5
There are no statistically signiﬁcant difference between groups, except for
sex, which females were signiﬁcantly higher when there are ≥ 2 vasospastic
conditions. Spherical equivalent is calculated as sphere+cylinder/2.
Data presented as mean ±SD and n (%).
APON indicates acquired optic nerve pit; IOP, intraocular pressure;
logMAR, logarithm of minimum angle of resolution; mmHg, treated or
nontreated: millimeters of mercury.
FIGURE 2. Bar graph of age distribution in patients with vaso-
spastic subtype of primary open-angle glaucoma. The number on
the top of each bar represents number of patients and the range
for each bin is depicted below each bar.
FIGURE 3. Bar graph of intraocular pressure distribution in
patients with vasospastic subtype of primary open-angle glau-
coma in each visit. The number on the top of each bar represents
number of visits and the range for each bin is depicted below
each bar.
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APON was recognized most frequently at the inferior
pole of the optic nerve in our patients (87%), which is higher
compared with previous studies (ranged between 70% and
80%).9,10,12,14 It has been suggested that lower pressure
POAG patients (identiﬁed by some as NTG) have thinner
neuroretinal rims compared with higher pressure POAG
controls, which is most marked in the inferior and infer-
otemporal optic disc regions.9,11,12 It has been also shown
that optic nerve cupping in glaucoma patients is deepest in
the inferior aspect of the disc where the connective tissue
bundles are thinnest and farthest apart.11,23,24
In this study, bilaterality of APON was found more
frequently than in some previous reports (30% in patients
with ≥ 2 vasospastic conditions and 48.6% in patients with
1, versus reports by Cashwell of 20.6% and Nduaguba of
16%)12,14 and comparable to the Ugurlu et al report of
48%.10 The longer follow-up in this case series may have
allowed for observation of a higher rate of bilateral APON
as progressive optic nerve damage occurred over time.
Our patients with APON had a higher female to male
ratio than previous studies (all of our patients with at least 2
vasospastic conditions and 92% of patients with 1 condition
were female).11 It has previously been shown that NTG,
migraine headaches, and Raynaud disease are more fre-
quent in females.10 There is also a higher association
between these systemic conditions and lower pressure
POAG22 as compared with higher pressure POAG, which
may be due to a common vascular pathology which underlie
both diseases.
Patients in this series were signiﬁcantly younger than
patients with POAG who have APON reported in previous
studies.10,12 We postulate that underlying systemic vaso-
spastic conditions play a role in optic nerve vulnerability to
damage. Studies in animal models of optic nerve ischemia
and glaucoma show that optic nerve ischemia causes
demonstrable and localized damage of the optic nerve
without IOP elevation.25–27 Ocular perfusion pressure (OPP)
is known to be related to systemic BP, and the relationship
between systemic BP and glaucoma is well established.25 In
previous population-based studies it has been shown that
lower BP and OPP are associated with glaucoma. The
Barbados Eye Survey28 showed that higher systolic and
diastolic BP can be considered as protective factors for
glaucoma, whereas individuals with lower OPP, especially
diastolic OPP (< 55 mmHg), have greater relative risk of
having glaucoma (relative risk= 3.2). Another factor can be
nocturnal BP dips; 24-hour BP monitoring has revealed
nocturnal dips as a risk factor for accelerated progression of
glaucoma. These dips can sometimes be iatrogenic, caused
by overmedication of systemic hypertension.29
The Los Angeles Latino Eye Study30 revealed that
lower mean OPP was associated with higher risk of glau-
coma in the population. Vigorous lowering of systemic BP
with medication might have the same effect on OPP and
have been shown to be associated with glaucoma,31,32
especially if it is associated with nocturnal hypotension.29,33
Low BP was seen in the majority of the patients in our
study; patients who did not have a history of low systolic BP
had a history of smoking. Smoking is suggested as a risk
factor for optic nerve vulnerability as well, via the nitric
oxide pathway, or other mechanisms.34 Cigarette smoking
can decrease the bioavailability of endothelium-derived
factors and cause dysfunctional vasomotor responses.35,36
Published data from clinical and animal studies have
showed that vascular dysfunction induced by smoking is
initiated by the reduced bioavailability of nitric oxide35,37,38
with subsequent vasoconstriction, stimulation of adhesion of
leukocytes to the endothelium and atherosclerosis.39,40
The relationship between systemic vascular structure
and optic nerve blood ﬂow has been shown in previous
studies. A relationship between ﬁngernail bed blood ﬂow
and optic nerve head ﬂow, especially in glaucomatous
patients, has been shown.41,42 In addition, not only was the
ﬂow in nail beds an indicator of optic nerve head ﬂow, but
hemorrhages in nail beds were predictors of optic disc
hemorrhages in glaucomatous patients, including NTG
patients.42–44
The rate of MD change for this syndrome in our study
was −0.33± 0.7 dB/year which is comparable to other
POAG patients and is signiﬁcantly higher than in normal
eyes.45,46 The fact that regardless of lower treated IOPs, the
ﬁnding that the visual ﬁeld worsens over time needs to be
considered in choosing treating options in these patients,
including surgery to achieve very low target pressures.
A limitation of the present study is the retrospective
design, small number of patients, and selection bias.
FIGURE 4. Examples of the optic nerve with the corresponding visual field. There is a spectrum of visual field defects depending on the
site of the acquired pits of the optic nerve.
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Untreated levels of IOP were available for two third of the
patients. Further prospective cohort studies of patients with
systemic vasospasm would help to clarify the hypotheses we
have laid out in this case series. The major goal of this study
is to show that this phenotype exists, and can be described,
despite the obvious limitations. As other studies suggest,
phenotyping is necessary for better understanding the rapid
development-related results of genomic technology.47
Of note, the expert panel did not examine all fundus
photographs as it was found to be time-consuming. How-
ever, it seems that this would have increased the likelihood
of this syndrome as there might be more APON patients
who meet the inclusion criteria that have not been picked up
by the initial screener, hence the incidence/prevalence rate
could have been underestimated.
In addition, as Jules Stein is a referral institute, we do
not have clean data about the baseline untreated IOP. As
this would be mainly self-reported, which increases the risk
of recall bias, these data were included in this study.
We have deﬁned a phenotype, “POAG, vasospastic
type” and propose that the predominant characteristics of
this phenotype include focal optic nerve damage in the form
of APON, POAG with progression at low IOP, middle-age
(40 to 60 y), female sex, and associated ﬁndings of Raynaud
phenomena, migraine, and low BP. We believe that these
systemic associations are signs of a vasospastic vascular
instability that predisposes the optic nerve to focal damage,
manifested as APON. Patients in this subgroup show pro-
gressive, focal optic nerve damage at a young age, and
identiﬁcation of such patients may guide the clinician to
pursue appropriately aggressive IOP-lowering and close
monitoring.
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